Adjuvant effects of bacillus calmette-guerin DNA or CpG-oligonucleotide in the immune response to Taenia solium cysticercosis vaccine in porcine

Scandinavian Journal of Immunology

Volumn 66, Issue 6, 2007, Pages 619-627

  Guo, Y J ^a   Wu, D ^a   Wang, K Y ^a   Sun, S H ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CD8 ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; DNA; GAMMA INTERFERON; IMMUNOGLOBULIN G2; RECOMBINANT C1 ANTIGEN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYSTICERCOSIS; DOMESTIC PIG; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOSTIMULATION; MONONUCLEAR CELL; MYCOBACTERIUM BOVIS; NONHUMAN; PARASITOSIS; PRIORITY JOURNAL; TAENIA SOLIUM; TH1 CELL; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; BCG VACCINE; CYSTICERCOSIS; IMMUNIZATION; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; OLIGODEOXYRIBONUCLEOTIDES; SWINE; SWINE DISEASES; TAENIA SOLIUM; TH1 CELLS; VACCINES, DNA;

EID: 36248936504     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2007.02013.x     Document Type: Article

References (34)

1. Pashine A, Valiante NM, Ulmer JB. Targeting the innate immune response with improved vaccine adjuvants. Nat Med 2005 4 (Suppl. S63 8.
2. Pisetsky DS. Immune activation by bacterial DNA: a new genetic code. Immunity 1996 5 : 303 10.
3. Krieg AM, Yi AK, Matson S et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995 374 : 546 9.
4. Hemmi H, Takeuchi O, Kawai T et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000 408 : 740 5.
5. Davis HL, Weeratna R, Waldschmidt TJ, Tygrett L, Schorr J, Krieg AM. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J Immunol 1998 160 : 870 6.
6. Jorgensen JB, Johansen LH, Steiro K, Johansen A. CpG DNA induces protective antiviral immune responses in Atlantic salmon (Salmo salar L.). J Virol 2003 77 : 11471 9.
7. Klinman DM, Barnhart KM, Conover J. CpG motifs as immune adjuvants. Vaccine 1999 17 : 19 25.
8. Sun SH, Wang JX, Chen RW. Molecular clong of cDNA encoding immunodiagnostic antigen of cysticercosis. Chin J Parasitol Parasitic Dis 1997 15 : 15 20.
9. Guo YJ, Sun SH, Zhang Y et al. Protection of pigs against Taenia solium cysticercosis using recombinant antigen or in combination with DNA vaccine. Vaccine 2004 22 : 3841 7.
10. Terrazas LI, Bojalil R, Govezensky T, Larralde C. Shift from an early protective Th1-type immune response to a late permissive Th2-type response in murine cysticercosis (Taenia crassiceps). J Parasitol 1998 84 : 74 81.
11. Toledo A, Fragoso G, Rosas G et al. Two epitopes shared by Taenia crassiceps and Taenia solium confer protection against murine T. crassiceps cysticercosis along with a prominent T1 response. Infect Immun 2001 69 : 1766 73.
12. Vazquez-Talavera J, Solis CF, Terrazas LI, Laclette JP. Characterization and protective potential of the immune response to Taenia solium paramyosin in a murine model of cysticercosis. Infect Immun 2001 69 : 5412 6.
13. Pontarollo RA, Rankin R, Babiuk LA et al. Monocytes are required for optimum in vitro stimulation of bovine peripheral blood mononuclear cells by non-methylated CpG motifs. Vet Immunol Immunopathol 2002 84 : 43 59.
14. Pittella JE. Neurocysticercosis. Brain Pathol 1997 7 : 681 93.
15. Sotelo J, Del Brutto OH, Roman GC. Cysticercosis. Curr Clin Top Infect Dis 1996 16 : 240 59.
16. White AC Jr. Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis, and management. Annu Rev Med 2000 51 : 187 206.
17. Wang QM, Sun SH, Hu ZL, Wu D, Wang ZC. Immune response and protection elicited by DNA immunisation against Taenia cysticercosis. Vaccine 2003 21 : 1672 80.
18. Plancarte A, Flisser A, Gauci CG, Lightowlers MW. Vaccination against Taenia solium cysticercosis in pigs using native and recombinant oncosphere antigens. Int J Parasitol 1999 29 : 643 7.
19. Chu RS, McCool T, Greenspan NS, Schreiber JR, Harding CV. CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies. Infect Immun 2000 68 : 1450 6.
20. Deml L, Schirmbeck R, Reimann J, Wolf H, Wagner R. Immunostimulatory CpG motifs trigger a T helper-1 immune response to human immunodeficiency virus type-1 (HIV-1) gp 160 envelope proteins. Clin Chem Lab Med 1999 37 : 199 204.
21. Stacey KJ, Blackwell JM. Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major. Infect Immun 1999 67 : 3719 26.
22. Sun S, Kishimoto H, Sprent J. DNA as an adjuvant: capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell responses to specific antigen. J Exp Med 1998 187 : 1145 50.
23. Cho YJ, Ahn BY, Lee NG, Lee DH, Kim DS. A combination of E. coli DNA fragments and modified lipopolysaccharides as a cancer immunotherapy. Vaccine 2006 24 : 5862 71.
24. Shoda LK, Kegerreis KA, Suarez CE et al. DNA from protozoan parasites Babesia bovis, Trypanosoma cruzi, and T. brucei is mitogenic for B lymphocytes and stimulates macrophage expression of interleukin-12, tumor necrosis factor alpha, and nitric oxide. Infect Immun 2001 69 : 2162 71.
25. Krieg AM, Yi AK, Matson S et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995 374 : 546 9.
26. Liang H, Nishioka Y, Reich CF, Pisetsky DS, Lipsky PE. Activation of human B cells by phosphorothioate oligodeoxynucleotides. J Clin Invest 1996 98 : 1119 29.
27. Weiner GJ, Liu HM, Wooldridge JE, Dahle CE, Krieg AM. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proc Natl Acad Sci U S A 1997 94 : 10833 7.
28. Hartmann G, Krieg AM. Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J Immunol 2000 164 : 944 53.
29. Krieg AM, Hartmann G, Yi AK. Mechanism of action of CpG DNA. Curr Top Microbiol Immunol 2000 247 : 1 21.
30. Rankin R, Pontarollo R, Ioannou X et al. CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucleic Acid Drug Dev 2001 11 : 333 40.
31. Mutwiri G, Pontarollo R, Babiuk S et al. Biological activity of immunostimulatory CpG DNA motifs in domestic animals. Vet Immunol Immunopathol 2003 91 : 89 103.
32. Yamada H, Gursel I, Takeshita F et al. Effect of suppressive DNA on CpG-induced immune activation. J Immunol 2002 169 : 5590 4.
33. Zhao Q, Temsamani J, Iadarola PL, Jiang Z, Agrawal S. Effect of different chemically modified oligodeoxynucleotides on immune stimulation. Biochem Pharmacol 1996 51 : 173 82.
34. Leifer CA, Verthelyi D, Klinman DM. Heterogeneity in the human response to immunostimulatory CpG oligodeoxynucleotides. J Immunother 2003 26 : 313 9.